Textured breast implant and methods of making same
US-2019029807-A1 · Jan 31, 2019 · US
US10898607B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10898607-B2 |
| Application number | US-201615373666-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 9, 2016 |
| Priority date | Mar 27, 2009 |
| Publication date | Jan 26, 2021 |
| Grant date | Jan 26, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are polyurethane polymer matrices with a porosity of from about 20 microns to about 90 microns that are useful in promoting closure and protection of incision sites; supporting the lower pole position of breast implants; and providing a partial or complete covering of breast implants to provide a beneficial interface with host tissue and to reduce the potential for malpositioning or capsular contracture. The disclosed matrices can be seeded with mammalian cells.
Opening claim text (preview).
What is claimed is: 1. A medical implant comprising: a breast prosthesis; and a matrix on said breast prosthesis, the matrix comprising a resorbable or bioerodible polymer component and a cellular component, wherein the polymer component comprises polycaprolactone soft segments having an amorphous rubbery phase, the matrix having a porosity conducive to cell growth and capable of providing a beneficial interface between the prosthesis and host tissue to enhance biocompatibility and reducing the potential for malpositioning or capsular contracture. 2. The implant of claim 1 wherein the cellular component comprises stem cells. 3. The implant of claim 1 wherein the cellular component comprises adipose cells. 4. The implant of claim 1 wherein the cellular component comprises stem cells and adipose cells. 5. The implant of claim 1 wherein the matrix forms at least a partial covering on said breast prosthesis. 6. The implant of claim 1 wherein the matrix forms a complete covering of said breast prosthesis. 7. The implant of claim 1 wherein the matrix has a pore size diameter of about 10 to about 1000 microns. 8. The implant of claim 1 wherein the matrix has a pore size diameter of from about 20 to about 90 microns.
characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title
Porous materials, {e.g. foams or sponges} · CPC title
comprising two or more cell types · CPC title
Mammary prostheses · CPC title
characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.